Second COVID-19 Vaccine Given Green Light, Major Credit Given to Daines
U.S. SENATE – Today, a second COVID-19 vaccine received emergency use authorization from the Food and Drug Administration (FDA). The vaccine, made by Moderna, will be distributed immediately. The accelerated development and delivery of Moderna’s COVID-19 vaccine was made possible as a result of Daines securing an initial $10 billion in the CARES Act in March to enable vaccine manufacturing and clinical trials to proceed simultaneously. “When the pandemic hit, I used my background as a chemical engineer as well as my experience in the private sector working with FDA regulated products to work with our top researchers, top scientists and our top innovators